The latest eBook by the University of Zurich explores their Center for Applied Biotechnology and Molecular Medicine’s (CABMM) latest translational research.
The eBook, named ‘Translational research in Zurich’, discusses CABMM’s technical expertise and research into a wide variety of research areas, such as:
- Good practices for manufacturing, laboratories, and clinics
- Musculoskeletal research
- Soft tissue research
- Ethics and animal protection
- Clinical trails
One important feature of CABMM is that it do not focus on one particular medical field, but rather on translational and interdisciplinary aspects. Furthermore, the CABMM offers expertise in regulatory affairs: Good Manufacturing Practice (GMP) and Good Laboratory Practice (GLP) were established by two leading members of the CABMM at the Institute for Regenerative Medicine and the Musculoskeletal Research Unit, respectively.
CABMM is an official competence centre of the University of Zurich, Switzerland, which is dedicated to fostering advances in clinically oriented, translational research in the fields of regenerative medicine, experimental medicine and surgery, applied biotechnology, and molecular medicine.
CABMM’s core competences include:
- Animal surgery
- Tissue engineering
- Regenerative medicine
- Molecular medicine
- Regulation of inflammation
- Bone and cartilage research including bone histology
- Cardiovascular research
CABMM aims to implement and support applications in biotechnology and molecular medicine by conducting research and development focusing on current issues in clinically relevant question and problems. To do this, we integrate existing research groups within this network and provide a working platform for collaborative research. In addition, the CABMM takes responsibility in training and mentoring junior scientists and newly founded groups.